Travere Therapeutics has won FDA approval for a drug that treats a rare autoimmune disorder that is typically first noticed as blood in the urine and can progress over time to end-stage kidney failure.
The…
McKinsey estimates that digital health solutions could cut global healthcare costs by $3 trillion per year by 2030. But we’ll only hit that number if people actually use the digital health solutions we build…
Continue Reading
Blue Shield of California (BSC) created its Wellvolution platform, a collection of wellbeing apps, with the intention of helping members with their diet, exercise, sleep and overall health. But until last month, it has…
Continue Reading
About 40% of Physicians Health Plan of Northern Indiana (PHP) members don’t have a primary care physician. The health plan aims to change that through a new partnership.
PHP announced last week that it is…
Clotting disorders can be treated by infusing patients with clotting proteins they lack, or with drugs that replace the function of these proteins. Gene therapies may soon become another option. Hemophilia A and B…
Continue Reading![Understanding the Healthcare Cybersecurity War and How to Defend Against It [Sponsored]](https://www.mediformatica.com/wp-content/uploads/2023/02/understanding-the-healthcare-cybersecurity-war-and-how-to-defend-against-it-sponsored.jpg)
The series of attacks on our healthcare infrastructure, particularly hospitals where ransomware attacks are on the rise, is a worrying trend that puts lives in jeopardy. A ransomware attack could mean the difference between…
Continue Reading
Due to Covid-19, many companies moved to a hybrid work model, leading to their buildings being largely underutilized. Blue Cross and Blue Shield of North Carolina (Blue Cross NC), is taking advantage of its quieter workspace to fight food insecurity in its local communities.
Due to fewer employees working onsite, Blue Cross…
Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca Health, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for…
Continue Reading
Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…
Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage.
The U.S. healthcare systems spent a whopping $301 billion on specialty drugs in 2021, a 43% increase since 2016. These specialty drugs accounted for half of the year’s total drug spending, and the list prices for specialty…
